Establishment Labs Holdings Inc.
ESTAHealthcareNASDAQMedical Devices · Last scanned Sep 9, 2026
Scan Results
Daily timeframeEstablishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa,. With a market capitalization of $2.24B, it sits in mid-cap territory. The company offers silicone gel-filled breast implants under the Motiva Implants brand.
Market Cap
$2.24B
Beta
1.05
P/E (TTM)
—
P/E (Fwd)
1254.83
EPS (TTM)
$-1.27
EPS (Fwd)
$0.06
ROE
-175.3%
ROA
-3.4%
Cash
$71.2M
Total Debt
$263.7M
Free CF
-$19.3M
52W Change
95.9%
Annual Financials
Cash vs Debt
Where ESTA stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, ESTA finished 0.58% above its 150-day moving average ($74.49) and 2.31% above its 200-day moving average ($73.23). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ESTA overbought or oversold?
At the September 3, 2026 close, ESTA's RSI(14) was 48.5, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $71.2M in cash, though total debt stands at $263.7M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow is running at -$19.3M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -175.3% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $161.7M (2022) to $211.1M (2025), reflecting a 31% increase over the period.
Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ESTA.